Perrigo Balance Sheet
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Perrigo financial position
At the end of fiscal 2025, Perrigo reported total assets of $8.54 billion, down 11.5% from a year earlier against total liabilities of $5.60 billion. Shareholders' equity stood at $2.94 billion, or 34.4% of assets. The company held $531.6 million in cash and equivalents against $3.64 billion of debt, a net debt position of $3.11 billion.
The current ratio (current assets divided by current liabilities) was 2.76, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.24.
Summary generated from market data by MetaCap's automated system. Methodology
Perrigo balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 531.60M | 558.80M | 751.30M | 600.70M | 1.86B | 631.50M | 354.30M | 551.10M | 678.70M | 622.30M |
| Receivables | 612.80M | 642.30M | 739.60M | 697.10M | 652.90M | 593.50M | 1.24B | 1.07B | 1.13B | 1.18B |
| Inventory | 1.15B | 1.08B | 1.14B | 1.15B | 1.02B | 1.06B | 967.30M | 878.00M | 806.90M | 795.00M |
| Total Current Assets | 2.80B | 2.48B | 2.83B | 2.72B | 3.86B | 3.13B | 2.73B | 2.90B | 2.82B | 2.81B |
| Property, Plant & Equipment | 898.70M | 917.80M | 916.40M | 926.30M | 864.10M | 864.60M | 774.20M | 829.10M | 833.10M | 870.10M |
| Goodwill | 2.05B | 3.32B | 3.53B | 3.49B | 3.00B | 3.10B | 3.10B | 3.98B | 4.18B | 4.05B |
| Intangible Assets | 4.76B | 4.50B | 5.00B | 5.01B | 3.68B | 3.89B | 4.75B | 4.43B | 4.75B | 4.53B |
| Total Assets | 8.54B | 9.65B | 10.81B | 11.02B | 10.43B | 11.49B | 11.30B | 10.98B | 11.63B | 13.87B |
| Accounts Payable | 474.50M | 495.20M | 477.70M | 537.30M | 411.20M | 451.60M | 520.20M | 474.90M | 450.20M | 471.70M |
| Short-Term Debt | 36.60M | 36.40M | 440.60M | 36.20M | 603.80M | 37.30M | 3.40M | 190.20M | 70.40M | 572.80M |
| Total Current Liabilities | 1.01B | 1.04B | 1.59B | 1.11B | 1.59B | 1.38B | 1.34B | 1.54B | 1.44B | 1.84B |
| Long-Term Debt | 3.60B | 3.58B | 3.63B | 4.07B | 2.92B | 3.53B | 3.37B | 3.05B | 3.27B | 5.22B |
| Total Liabilities | 5.60B | 5.33B | 6.04B | 6.18B | 5.27B | 5.83B | 5.50B | 5.32B | 5.46B | 7.91B |
| Shareholders' Equity | 2.94B | 4.32B | 4.77B | 4.84B | 5.15B | 5.66B | 5.80B | 5.67B | 6.17B | 5.96B |
| Retained Earnings | -3.68B | -2.25B | -2.08B | -2.07B | -1.93B | -1.86B | -1.70B | -1.84B | -1.98B | -2.10B |
| Total Debt | 3.64B | 3.62B | 4.07B | 4.11B | 3.52B | 3.56B | 3.37B | 3.24B | 3.34B | 5.80B |
| Net Cash (Debt) | -3.11B | -3.06B | -3.32B | -3.51B | -1.66B | -2.93B | -3.01B | -2.69B | -2.66B | -5.17B |
| Shares Outstanding | 137.60M | 136.50M | 135.50M | 134.70M | — | — | — | — | 140.80M | 143.40M |
This table shows 10 annual periods of Perrigo's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PRGO's reporting calendar. What is a balance sheet?